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ABSTRACT: Humans are exposed to a huge amount of environmental pollutants called 
endocrine disrupting chemicals (EDCs). These molecules interfere with the homeostasis of the 
body, usually through mimicking natural hormones leading to activation or blocking their 
receptors. Many of these compounds have been associated to a broad range of diseases including 
the development or increased susceptibility to breast cancer, the most prevalent cancer in woman 
worldwide, according to the World Health Organization. Thus, this article presents a virtual 
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high-throughput screening (vHTS) to evaluate the affinity of proteins related to breast cancer, 
such as ESR1, ERBB2, PGR, BCRA1 and SHBG, among others, with EDCs from urban sources. 
A blind docking strategy was employed to screen each protein-ligand pair by triplicate in 
AutoDock Vina 2.0, using the computed binding affinities as ranking criteria. The three-
dimensional structures were previously obtained from EDCs DataBank and Protein Data Bank, 
prepared and optimized by SYBYL X-2.0. Some of the chemicals that exhibited the best affinity 
scores for breast cancer proteins in each category were 1,3,7,8-tetrachlorodibenzo-p-dioxin, 
bisphenol A derivatives, perfluorooctane sulfonic acid and benzo(a)pyrene, for catalase, several 
proteins, sex hormone-binding globulin and cytochrome P450 1A2, respectively. An 
experimental validation of this approach was performed with a complex that gave a moderate 
binding affinity in silico, the sex hormone binding globulin (SHBG) and bisphenol-A (BPA) 
complex. The protein was obtained using DNA recombinant technology and the physical 
interaction with BPA assessed through spectroscopic techniques. BPA binds on the recombinant 
SHBG, and this results in an increase of its alpha helix content. In short, this work shows the 
potential of several EDCs to bind breast cancer associated proteins, as a tool to prioritize 
compounds to perform in vitro analysis to benefit the regulation or exposure prevention by the 
general population. 
1. INTRODUCTION 
Endocrine disrupting chemicals (EDCs) are a broad range of molecules with potential to affect 
the endocrine system through different ways, metabolic, epigenetic and DNA damage1b-e. These 
chemicals were classified for first time in the 90’s and were defined by the Environmental 
Protection Agency (EPA) as substances with the ability to interfere with the synthesis, secretion, 
transport, binding, action, or elimination of natural hormones in the body that are responsible for 
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the maintenance of homeostasis, reproduction, development, and/or behavior2. Currently, EPA 
estimates there exist approximately 10,000 EDCs among the common daily exposures that could 
impose any risk of disease3. Some critical points in the debate around these compounds include 
the potential to affect the health of humans and wildlife, as well as their progeny4; the massive 
volume of production of some of them and the chronic exposure to the general population 
through the environment and everyday products5. These points have enhanced the scientific 
concern regarding the safety of these chemicals in recent years.  
 
The exposure to EDCs induces adverse effects, specially related to reproduction, development 
and different cancer types6, including breast cancer7 , which according to the World Health 
Organization (WHO) is the most common cancer in women, both in the developed and less 
developed world, estimating that worldwide over 508,000 women died in 2011 due to this 
disease (http://www.who.int/cancer/detection/breastcancer/en/index1.html). The classic hallmark 
mechanism in breast cancer is the activation of estrogen receptor, for that reason the responses 
due to EDCs exposures have been mainly explored and attributed to this signaling pathway1a. In 
general, the understanding on the underlying mechanisms of breast cancer8 are limited because 
of its complexity and heterogeneity; nevertheless, there are some proteins recognized as 
important in its initiation and progression, specially hormone receptors such as estrogen receptor 
(ESR1), progesterone receptor (PGR), and other proteins, in particular, the human epidermal 
growth factor receptor 2 (HER-2), breast cancer type 1 susceptibility protein (BRCA1) and 
breast cancer type 2 susceptibility protein (BRCA2)9.  
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Currently, thousands of environmental chemicals are subject to regulatory review for their 
potential as EDCs, and in vitro high-throughput screening (HTS) assays have emerged as a 
potential tool for prioritizing chemicals for whole animal tests10. However, computational 
toxicology approaches are needed to help to prioritize chemicals for screening11, focusing on 
their interaction with critical disease pathways12. In this work we evaluated in silico the potential 
of EDCs to target breast cancer proteins, using a virtual high-throughput screening (vHTS) and 
an in vitro validation through spectroscopic methods for one of the predicted protein/ligand 
complexes.  
 
2. RESULTS  
2.1.Text mining 
Based on the data mining performed on FABLE, 294 genes/proteins were found to be related 
to breast cancer (≥100 citations in PubMed) (Suppl. Table 1), and a total of 133 were suitable for 
docking studies and employed for further analysis. This selection was complemented adding 
proteins recently discovered as important in breast cancer, as well as with nuclear receptors and 
cell cycle regulation proteins. Finally, a total of 189 proteins were selected for the vHTS with 
EDCs. 
 
2.2.High-throughput virtual screening 
A total of 305 EDCs were docked with the proteins related to breast cancer selected in the 
previous step. The EDCs were classified according to the potential sources of exposures in four 
groups: dioxins and related molecules, plastics and other types of polymers, everyday products 
and miscellaneous. Results were ranked according to the affinity scores obtained in AutoDock 
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Vina13. Clustered heat maps of the affinity scores of EDCs against breast cancer proteins are 
presented for each category as supplementary material (Suppl. Figures 1-4). 
 
The virtual screening allowed the identification of protein-ligand pairs with high affinity, 
candidates to be tested in vitro and in vivo for breast cancer in further studies. In the following 
sections the results in each group of EDCs, according to the exposure source, are presented. 
 
2.3.Dioxins and related molecules  
The main cluster in the heat map of the virtual screening of breast cancer proteins with dioxins 
and related molecules (Suppl. Figure 1 and Suppl. Table 2) indicates that these interact mostly 
with a group of proteins, including catalase (CAT); retinoic acid receptor beta (RARB); SHBG; 
PGR; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PIK3CA); 
nuclear receptor ROR-gamma (RORC); nuclear receptor ROR-alpha (RORA); adiponectin 
(ADIPOQ); cytochrome P450 3A4 (CYP3A4); phosphatidylinositol 4,5-bisphosphate 3-kinase 
catalytic subunit gamma isoform (PIK3CG) and apolipoprotein D (APOD). Therefore, the 
underlying mechanisms by which these EDCs elicit their effects could be associated to signaling 
pathways involved in cell proliferation and oxidative stress, among others. 
 
The complexes that presented the highest affinity score in this group are CAT/1,3,7,8-
tetrachlorodibenzo-p-dioxin (Figure 1), and 2,3,4,7-tetrachlorodibenzofuran with the protein 
cytochrome P450 1A2 (CYP1A2, Figure 2). The top ranking of the complexes formed by EDCs 
in this group with breast cancer proteins is showed in Table 1. 
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Figure 1. Three-dimensional view of the (A) CAT/1,3,7,8-tetrachlorodibenzo-p-dioxin, (B) 
showing the binding site and interactions predicted by LigandScout 3.1.  
 
Figure 2. Three-dimensional view of the (A) CYP1A2/2,3,4,7-tetrachlorodibenzofuran, (B) 
showing the binding site and interactions predicted by LigandScout 3.1. The blue arrows represent aromatic 
ring interactions. 
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Table 1. Dioxins and related molecules with best affinity scores (<-10.0 kcal/mol) after docking 
with breast cancer associated proteins.   
Short name PDB EDCs CID Affinity (kcal/mol) 
CAT 1DGF 1,3,7,8-tetrachlorodibenzo-p-dioxin 149104 -10.3 
CYP1A2 2HI4 2,3,4,7-tetrachlorodibenzofuran 55111 -10.2 
 
2.4.Plastics and other types of polymers  
The docking simulation showed that several EDCs in this category have the potential to bind 
breast cancer proteins (Suppl. Table 3 and Suppl. Figure 2). However, the derivatives of the 
well-known plasticizer BPA presented the best affinities, being located the top of the ranking 
table (Table 2).  
 
Table 2. EDCs in plastics and other types of polymers with best affinity scores (<-10.0 kcal/mol) 
after docking with breast cancer associated proteins.   
Short name PDB EDCs CID Affinity (kcal/mol) 
SRC 2H8H bisphenol M 3292100 -10.8 
ESRRG 2E2R bisphenol AF 73864 -10.8 
RXRB 1H9U bisphenol M 3292100 -10.7 
     
VDR 1IE9 bisphenol A dimethacrylate 76739 -10.3 
VDR 1IE9 bisphenol M 3292100 -10.3 
SHBG 1F5F bisphenol M 3292100 -10.3 
RARB 4DM6 bisphenol M 3292100 -10.2 
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ESRRG 2E2R bisphenol B 66166 -10.2 
CYP1A2 2HI4 dihydroxymethoxychlor olefin 84677 -10.1 
HBA1 1A01 2,4,6-triphenyl-1-hexene 45356241 -10.1 
CYP1A2 2HI4 diphenyl-p-phenylenediamine 6319 -10.1 
 
The chemical structures of  BPA and its analogs are presented in Figure 3, as well as their 
potential targets in breast cancer according to the vHTS, and a functional protein association 
network generated by STRING14.  
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Figure 3. A) Chemical structure of BPA and B) its analogs showing the interactions with breast 
cancer proteins according to docking studies, and the analysis of the protein-protein interactions 
by STRING v.1014. 
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The two complexes with the best affinity score were proto-oncogene tyrosine-protein kinase 
Src (SRC)/bisphenol M and estrogen-related receptor gamma (ESRRG)/ bisphenol AF (-10.8 
kcal/mol). This is an interesting finding, as bisphenol AF (BPAF), is considered a new bisphenol 
analogue used as raw material in plastic industry; however, little is known about its occurrence in 
the environment and the potential associated risk15. The three-dimensional view of these 
complexes and their interactions are presented in Figures 4-5. Most of the interactions were 
hydrophobic in nature; however there are some hydrogen bond donor features that suggest the 
presence of hydrogen bonds between the ligand and the surrounding residues. 
 
 
Figure 4. Three-dimensional view of the (A) SRC/bisphenol M complex, (B) showing the 
binding site and interactions predicted by LigandScout 3.1. The green arrows represent hydrogen-bond donor 
features. 
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Figure 5. Three-dimensional view of the (A) ESRRG/bisphenol AF complex, (B) showing the 
binding site and interactions predicted by LigandScout 3.1. The green arrows represent hydrogen-bond donor 
features. 
 
Everyday products 
A broad range of EDCs presents in cosmetics, household products, drugs and personal care 
products, among others, exhibited good affinity for proteins involved in breast cancer (Suppl. 
Table 4. and Suppl. Figure 3). The complexes with the best affinity scores in this group were the 
perfluorooctane sulfonic acid with the hormone transporter SHBG (Figure 6), and the 
RARB/AHTN complex (Figure 7). 
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Figure 6. Three-dimensional view of the (A) SHBG/perfluorooctane sulfonic acid complex, (B) 
showing the binding site and interactions predicted by LigandScout 3.1. The red arrows represent hydrogen-
bond acceptor features. 
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Figure 7. Three-dimensional view of the (A) RARB/AHTN complex, (B) showing the binding 
site and interactions predicted by LigandScout 3.1.  
 
Other complexes that also exhibited good affinity scores are presented in Table 3.  
 
Table 3. EDCs in everyday products with best affinity scores (<-10.0 kcal/mol) after docking 
with breast cancer associated proteins. 
Short 
name PDB EDCs CID Keywords 
Affinity 
(kcal/mol) 
SHBG 1F5F perfluorooctane 
sulfonic acid 
74483 Household products -10.4 
RARB 4DM6 AHTN 89440 Cosmetics -10.4 
GSTP
1 
3N9J Emodin 3220 Drugs -10.2 
VDR 1IE9 3-(4-
methylbenzylide
ne)camphor 
6434217 Cosmetics -10.2 
SHBG 1F5F 3-(4-
methylbenzylide
ne)camphor 
6434217 Cosmetics -10.1 
SERPI
NB5 
1WZ9 Triclocarban 7547 Antimicrobial, personal care 
products, household 
products 
-10.1 
CAT 1DGF Emodin 3220 Drugs -10.1 
 
 
2.5.Miscellaneous 
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The molecules that exhibited the best affinities in this category were mostly related to 
combustion, some of them are 3-hydroxy-benzo(a)pyrene, (benzo(a)pyrene and 6-
hydroxychrysene (Suppl. Table 5 and Suppl. Figure 4.). The best affinity score, was predicted for 
the complex CYP1A2/benzo(a)pyrene (Figure 8). 
 
 
Figure 8. Three-dimensional view of the (A) CYP1A2/benzo(a)pyrene complex, (B) showing 
the binding site and interactions predicted by LigandScout 3.1. The blue arrows represent aromatic ring 
interactions. 
 
Other complexes with EDCs from different sources also exhibited good affinity scores (Table 
4). However, most of them were polycyclic aromatic hydrocarbons (PAHs). 
 
Table 4. Miscellaneous EDCs with best affinity scores (<-10.0 kcal/mol) after docking with 
breast cancer associated proteins. 
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Short 
name PDB EDCs CID Keywords 
Affinity 
(kcal/mol) 
CYP1A2 2HI4 benzo(a)pyrene 2336 combustion, wood, cigarette -13.2 
CYP1A2 2HI4 benzanthrone 6697 
industrial pollutant, 
combustion -13.0 
CYP1A2 2HI4 
6-
hydroxychrysene 37766 metabolite, combustion -12.1 
CYP1A2 2HI4 1-hydroxypyrene 21387 metabolite, combustion -12.0 
MYLK4 2X4F 
3-hydroxy-
benzo(a)pyrene 25890 combustion -12.0 
RARB 4DM6 benzo(a)pyrene 2336 combustion, wood, cigarette -12.0 
MYLK4 2X4F benzo(a)pyrene 2336 combustion, wood, cigarette -11.9 
SHBG 1F5F benzo(a)pyrene 2336 combustion, wood, cigarette -11.8 
CYP1A2 2HI4 
1,9-
dimethylphenant
hrene 34454 
environmental pollutant, 
cigarette -11.8 
CAT 1DGF 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.8 
RARB 4DM6 benzanthrone 6697 
industrial pollutant, 
combustion -11.7 
CAT 1DGF benzo(a)pyrene 2336 combustion, wood, cigarette -11.6 
CAT 1DGF 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -11.6 
CHEK2 2W0J benzo(a)pyrene 2336 combustion, wood, cigarette -11.5 
CHEK2 2W0J 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -11.5 
MYLK4 2X4F 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -11.5 
SHBG 1F5F 2-
hydroxybenzo(a)
42027 metabolite, combustion -11.4 
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pyrene 
CYP3A4 1TQN benzo(a)pyrene 2336 combustion, wood, cigarette -11.4 
CHEK2 2W0J 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.4 
CYP3A4 1TQN 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.3 
CYP3A4 1TQN 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -11.3 
CYP2B6 3IBD 
6-
hydroxychrysene 37766 metabolite, combustion -11.3 
SHBG 1F5F 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.3 
PIK3CA 3HHM benzo(a)pyrene 2336 combustion, wood, cigarette -11.2 
ADIPOQ 4DOU benzo(a)pyrene 2336 combustion, wood, cigarette -11.2 
ADIPOQ 4DOU 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -11.2 
PIK3CA 3HHM 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.2 
ESR2 1QKM benzo(a)pyrene 2336 combustion, wood, cigarette -11.1 
CHEK2 2W0J 
6-
hydroxychrysene 37766 metabolite, combustion -11.1 
ADIPOQ 4DOU 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.1 
CYP1A2 2HI4 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.1 
CDK2 1AQ1 
3-hydroxy-
benzo(a)pyrene 25890 combustion -11.0 
SHBG 1F5F 
6-
hydroxychrysene 37766 metabolite, combustion -11.0 
HPGDS 2VCQ 2-
hydroxybenzo(a)
42027 metabolite, combustion -11.0 
Page 16 of 50
ACS Paragon Plus Environment
Chemical Research in Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 17 
pyrene 
ADIPOQ 4DOU 
6-
hydroxychrysene 37766 metabolite, combustion -11.0 
CDK2 1AQ1 benzo(a)pyrene 2336 combustion, wood, cigarette -11.0 
CDK2 1AQ1 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.9 
SRC 2H8H benzo(a)pyrene 2336 combustion, wood, cigarette -10.9 
RARG 2LBD benzo(a)pyrene 2336 combustion, wood, cigarette -10.9 
MYLK4 2X4F 
6-
hydroxychrysene 37766 metabolite, combustion -10.9 
MYLK4 2X4F benzanthrone 6697 
industrial pollutant, 
combustion -10.9 
SHBG 1F5F benzanthrone 6697 
industrial pollutant, 
combustion -10.8 
NME1 1UCN benzo(a)pyrene 2336 combustion, wood, cigarette -10.8 
RXRG 2GL8 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.8 
SRC 2H8H 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.8 
SRC 2H8H 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.8 
PIK3CA 3HHM 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.8 
CYP2B6 3IBD benzo(a)pyrene 2336 combustion, wood, cigarette -10.8 
RARB 4DM6 1-hydroxypyrene 21387 metabolite, combustion -10.8 
RXRB 1H9U benzo(a)pyrene 2336 combustion, wood, cigarette -10.7 
RXRB 1H9U 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.7 
AR 2AM9 2-
hydroxybenzo(a)
42027 metabolite, combustion -10.7 
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pyrene 
PPARD 2AWH benzo(a)pyrene 2336 combustion, wood, cigarette -10.7 
RXRA 2P1T HHCB 91497 fragrance -10.7 
MYLK4 2X4F 1-hydroxypyrene 21387 metabolite, combustion -10.7 
STRADA/
MO25  3GNI 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.7 
RARB 4DM6 
1,9-
dimethylphenant
hrene 34454 
environmental pollutant, 
cigarette -10.7 
HPGDS 2VCQ benzo(a)pyrene 2336 combustion, wood, cigarette -10.6 
HPGDS 2VCQ 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.6 
AR 2AM9 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.6 
APOD 2HZQ benzo(a)pyrene 2336 combustion, wood, cigarette -10.6 
APOD 2HZQ 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.6 
RXRA 2P1T benzo(a)pyrene 2336 combustion, wood, cigarette -10.6 
CAMK2B 3BHH benzo(a)pyrene 2336 combustion, wood, cigarette -10.6 
RARB 4DM6 
6-
hydroxychrysene 37766 metabolite, combustion -10.6 
GSTP1 3N9J 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.6 
CAT 1DGF 
6-
hydroxychrysene 37766 metabolite, combustion -10.6 
AR 2AM9 benzo(a)pyrene 2336 combustion, wood, cigarette -10.6 
CAT 1DGF benzanthrone 6697 
industrial pollutant, 
combustion -10.5 
RARB 4DM6 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.5 
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NME1 1UCN 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.5 
PPARD 2AWH 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.5 
APOD 2HZQ 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.5 
STRADA/
MO25  3GNI benzo(a)pyrene 2336 combustion, wood, cigarette -10.5 
MAPK1 3I60 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.5 
RPS6KB1 4L3J benzo(a)pyrene 2336 combustion, wood, cigarette -10.5 
RPS6KB1 4L3J 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.5 
ESR2 1QKM 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.5 
RPS6KB1 4L3J 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.5 
CYP1A2 2HI4 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.4 
NME1 1UCN 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.4 
PPARD 2AWH 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.4 
RXRG 2GL8 benzo(a)pyrene 2336 combustion, wood, cigarette -10.4 
RPS6KA1 2WNT benzo(a)pyrene 2336 combustion, wood, cigarette -10.4 
PIK3CG 3MJW benzo(a)pyrene 2336 combustion, wood, cigarette -10.4 
GSTP1 3N9J benzo(a)pyrene 2336 combustion, wood, cigarette -10.4 
MET 1R0P benzo(a)pyrene 2336 combustion, wood, cigarette -10.4 
Page 19 of 50
ACS Paragon Plus Environment
Chemical Research in Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 20 
RELA 2O61 benzo(a)pyrene 2336 combustion, wood, cigarette -10.4 
CAMK2B 3BHH 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.4 
CAMK2B 3BHH 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.4 
NQO1 1D4A 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.3 
RORA 1N83 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.3 
PGR 1SQN 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.3 
RXRA 2P1T 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.3 
RORC 3L0L benzo(a)pyrene 2336 combustion, wood, cigarette -10.3 
PIK3CG 3MJW 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.3 
CXCR4 3ODU benzo(a)pyrene 2336 combustion, wood, cigarette -10.3 
SHBG 1F5F 1-hydroxypyrene 21387 metabolite, combustion -10.2 
MET 1R0P 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
MET 1R0P 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.2 
PGR 1SQN benzo(a)pyrene 2336 combustion, wood, cigarette -10.2 
PGR 1SQN 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
NR3C2 2AA2 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
AR 2AM9 
6-
hydroxychrysene 37766 metabolite, combustion -10.2 
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PPARD 2AWH 
6-
hydroxychrysene 37766 metabolite, combustion -10.2 
MSH2 2O8B benzo(a)pyrene 2336 combustion, wood, cigarette -10.2 
RPS6KA1 2WNT 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.2 
FGFR2 3B2T 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.2 
ARF-BP1 3H1D benzo(a)pyrene 2336 combustion, wood, cigarette -10.2 
MAPK1 3I60 benzo(a)pyrene 2336 combustion, wood, cigarette -10.2 
MAPK1 3I60 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
GSTP1 3N9J 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
CHKA 2CKO 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
RARG 2LBD 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
HPGDS 2VCQ aurin 5100 analytical chemistry -10.2 
RPS6KA1 2WNT 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
PIK3CA 3HHM 
6-
hydroxychrysene 37766 metabolite, combustion -10.2 
MTOR 4JSN 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.2 
PIK3CA 3HHM benzanthrone 6697 
industrial pollutant, 
combustion -10.1 
CDK2 1AQ1 
6-
hydroxychrysene 37766 metabolite, combustion -10.1 
CAT 1DGF 1-hydroxypyrene 21387 metabolite, combustion -10.1 
SHBG 1F5F 1,9-
dimethylphenant
34454 
environmental pollutant, 
cigarette -10.1 
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hrene 
RORA 1N83 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.1 
NR3C2 2AA2 benzo(a)pyrene 2336 combustion, wood, cigarette -10.1 
NR3C2 2AA2 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.1 
ESRRG 2E2R 
3-
monobromobisph
enol A 656688 metabolite, flame retardants -10.1 
MYLK4 2X4F 
1,9-
dimethylphenant
hrene 34454 
environmental pollutant, 
cigarette -10.1 
ESR1 3ERT 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.1 
RORC 3L0L 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.1 
PPARG 3LMP 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.1 
GSTP1 3N9J benzanthrone 6697 
industrial pollutant, 
combustion -10.1 
ADIPOQ 4DOU benzanthrone 6697 
industrial pollutant, 
combustion -10.1 
MTOR 4JSN benzo(a)pyrene 2336 combustion, wood, cigarette -10.1 
ESR2 1QKM 
3-hydroxy-
benzo(a)pyrene 25890 combustion -10.1 
ADIPOQ 4DOU 
bis(4-
hydroxyphenyl)[(
2-
phenoxysulfonyl)
phenyl]methane 130780 analytical chemistry -10.1 
CXCR4 3ODU 
2-
hydroxybenzo(a)
pyrene 42027 metabolite, combustion -10.1 
Page 22 of 50
ACS Paragon Plus Environment
Chemical Research in Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 23 
 
2.6.BPA/SHBG interaction 
The interaction of BPA or its derivatives and breast cancer associated proteins is of special 
concern, as humans are exposed to these chemicals through contact with different products that 
contain them, especially through foods that have been in contact with packaging materials that 
may release these pollutants16. Several authors have proposed these chemicals affect the function 
of multiple organs and increase the risk of breast cancer in mice17. In breast cancer, many 
proteins play a pivotal role in the pathogenesis of this disease. However, SHBG is a small and 
stable protein with high affinity for estrogens and androgens that has been found in breast tissue 
and cell lines through immunostaining18, being the major and specific binding protein for 
testosterone and estradiol. Besides, decreased circulating levels of this protein have been 
observed in breast cancer patients possibly indicating higher bioavailable estrogens19. These 
were the main reasons we use to choose it to obtain it and to validate our docking predictions. 
Therefore, we selected the hormone transporter SHBG20, as this exhibited a good affinity score 
in AutoDock Vina (-8.2 kcal/mol), to computationally assess their interactions and 
conformational changes by CD. Moreover, the data reported in the scientific literature suggest 
human SHBG may transport some xenostrogens into the plasma and modulate their 
bioavailability to cell tissues21, which could disrupt the natural hormones balance. 
 
The conformational analysis performed in LigandScout 3.122 suggests that BPA interacts in the 
binding pocket of SHBG (Figure 9). Most of the interactions of BPA were hydrophobic 
(Met139A, Leu80A, Val112A), although one residue in the binding site exhibited hydrogen bond 
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donor and acceptor features (Thr60A), and an aromatic ring interaction was predicted for BPA 
and one of the amino acids of the contact residues (Phe67A). 
 
 
Figure 9. Three-dimensional view of the (A) SHBG/ bisphenol A complex, (B) showing the 
binding site and interactions predicted by LigandScout 3.1. The green arrows represent hydrogen-bond donor 
features, the red arrows show the hydrogen-bond acceptor features, and the blue arrows indicate aromatic ring interactions. 
 
The three-dimensional view of the complex also indicates the position of BPA deep in the 
binding site, which can contribute to an elevated affinity. It should be pointed out that 
conformational changes should have occurred to allow this docking pose.  
 
2.7.Protein expression and purification 
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Recombinant SHBG was expressed and purified from E. coli C41(DE3) cells using Dynabeads 
His-Tag Isolation and Pulldown. SDS- PAGE electrophoresis gel of the purified protein is 
presented in Suppl. Figure 5. 
 
2.8.Microscale thermophoresis 
After FPLC purification a clear separation between the protein and the dye, and a small portion 
of the total protein was labeled in the collected fractions (75-77) was observed in the spectra. 
Therefore, this study was used with qualitative purposes, which was enough to evaluate the 
functionality of the recombinant protein to bind the ligand. 
 
The curve of the MST analysis and the fluorescence data is presented in Suppl. Figure 6. This 
shows that SHBG has the tendency to bind BPA at around 1µM of BPA, although a saturation 
point was not reached. This could be the result of a low protein labelling with a high non-labeled 
protein ratio, which makes more difficult to reach the saturation point as the total protein 
concentration was high in the sample.  
 
2.9.Circular dichroism 
The correct folding of the recombinant protein was assessed by CD. According to PDB23, the 
secondary structure of SHBG (PDB ID: 1F5F) consist of 4% alpha helix and 40% beta sheets. 
This correlates with the values obtained by circular dichroism of the SHBG dissolved in PBS at 
pH 7.4: helix=6.3% and beta sheets=40.6% (strand 1=26.3% and strand 2=14.3%). The results of 
the secondary structure analysis, according to the DichroWeb24 software are presented in Figure 
10. 
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Figure 10. Changes in the secondary structure of SHBG after incubation with BPA. 
 
At time zero (t=0), no main differences were observed for the contents of helix or strands of 
the samples of SHBG with BPA 1.5 x 10-5 and 4.5 x 10-5 M. However, after overnight incubation 
(t=O/N), an increase in the helix content of the protein was observed, with a percentage increase 
of more than 20% in both cases. The CD spectra for 1.5 x 10-5 and 4.5 x 10-5 M of BPA at time 
zero and overnight are presented in Figure 11. The Dunn’s test did not show statistical significant 
differences between the medians of the SHBG sample and the SHBG/BPA samples in time zero. 
However, a statistical difference was revealed for the comparison of each sample after overnight 
incubation with the protein sample, and the SHBG/BPA samples in time zero (Table 5). 
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Figure 11. Processed circular dichroism spectra of SHBG and SHBG incubated with 1.5 x 10-5 
and 4.5 x 10-5 M of BPA at time zero (t=0) and overnight (t=O/N) by DichroWeb24. 
 
Table 5. Results of the statistical analysis. 
Dunn's multiple comparisons test Mean rank diff, Significant 
   SHBG vs. SHBG/BPA (15µM, t=0) -26,71 No 
SHBG vs. SHBG/BPA (45µM, t=0) 7,735 No 
SHBG vs. SHBG/BPA (15µM, t=O/N) 101,5 Yes 
SHBG vs. SHBG/BPA (45µM, t=O/N) 78,19 Yes 
SHBG/BPA (15µM, t=0) vs. SHBG/BPA (45µM, t=0) 34,44 No 
SHBG/BPA (15µM, t=0) vs. SHBG/BPA (15µM, t=O/N) 128,2 Yes 
SHBG/BPA (15µM, t=0) vs. SHBG/BPA (45µM, t=O/N) 104,9 Yes 
SHBG/BPA (45µM, t=0) vs. SHBG/BPA (15µM, t=O/N) 93,78 Yes 
SHBG/BPA (45µM, t=0) vs. SHBG/BPA (45µM, t=O/N) 70,45 Yes 
SHBG/BPA (15µM, t=O/N) vs. SHBG/BPA (45µM, t=O/N) -23,33 No 
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3. DISCUSSION 
In this work we studied the potential of EDCs from urban sources to target breast cancer 
proteins using an in silico approach. The macromolecules CAT, RARB, SHBG, PGR and 
PIK3CA presented the highest number of theoretical complexes with xenoestrogens (affinity ≤ -
8.0 kcal/mol). These are pivotal in breast cancer and could be modulating the response to EDCs 
exposure through metabolic ways. CAT is an antioxidant enzyme that helps to control oxidative 
stress and DNA damage associated to EDCs exposure and breast cancer development25; RARB 
modulates the proliferation of breast cancer cells by limiting the growth and promoting the 
apoptosis26; SHBG transport steroid hormones through the bloodstream, limiting their free 
fraction, its binding with xenoestrogens could increase the bioavailable estradiol augmenting the 
risk of breast cancer27; PGR is a well-known marker that together with the ER status is used in 
the immunohistochemically prognosis of this disease, except for the triple negative subtype, that 
comprises around 15% of the cases28; and PIK3CA has an important role in neoplasia, and 
aberrations in its pathway or in the gene that codifies it results in an increased risk of cancer29.  
 
Several of the tested small molecules exhibited high docking affinity in computer simulations 
and should be prioritized for in vitro and in vivo assays, in addition some of them showed to be 
frequent hitters as they act as promiscuous compounds binding different targets30. The visual 
inspection of the docking affinity heat maps (see Supplementary material) indicates that the 
highest density of protein-ligand pairs with potential to interact between them is presented for 
dioxins and related molecules. Therefore, this may be the principal source of EDCs interacting 
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with the metabolic pathways involved in breast cancer. The number of potential targets was 
followed for the categories: miscellaneous, everyday products, and plastics and other types of 
polymers, respectively.  
 
The compounds with the highest number of theoretical targets among the breast cancer 
proteins were the PAHs: 2-hydroxybenzo(a)pyrene, benzo(a)pyrene and 3-hydroxy-
benzo(a)pyrene. In the group of plastics and other type of polymers, the most frequent hitter was 
bisphenol M, followed by the synthetic compound used in the production of thermally stable 
polyesters and polycarbonates, 4,4'-(octahydro-4,7-methano-5H-inden-5-ylidene) bisphenol, and  
the styrene trimer, 2,4,6-triphenyl-1-hexene, generated in the decomposition of plastics and 
released from containers to food31. For everyday products, the most promiscuous compound 
found was the perfluorooctane sulfonic acid. This is interesting, as EDCs can be interacting with 
many different pathways through protein-ligand interactions making their mechanisms and 
effects more difficult to understand and control. 
 
The two complexes with the highest affinity scores in the group of dioxins and related 
molecules were: CAT/1,3,7,8-tetrachlorodibenzo-p-dioxin and CYP1A2/2,3,4,7-
tetrachlorodibenzofuran. However, other chemicals in this group also presented very good 
affinity (≤-9.5 kcal/mol) for CYP1A2 (See suppl. Material Rank_Dioxins), which is in 
agreement with the scientific literature that indicates this kind of compounds have been found to 
bind and induce CYP1A232. The eventual binding of 1,3,7,8-tetrachlorodibenzo-p-dioxin to CAT 
may have an effect in the hydrogen peroxide binding an then in the oxidative stress response.  
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EDCs from plastics and other types of polymers constitute a special category due to the 
increased use of these materials in human life, and the annual tendency to augment progressively 
their already high volumes of production33. One of the plasticizers that have received more 
attention in the last decade is the BPA, a monomer used in polycarbonate plastics and epoxy 
resins frequently found in food containers, which as a result of restrictive regulations has started 
to be replaced by other analogues34. Surprisingly, some of these derivatives (bisphenol M, 
bisphenol B, BPAF, dihydroxymethoxychlor olefin and bisphenol A dimethacrylate) are on the 
top of the complexes with highest docking affinity for breast cancer proteins in silico (Table 2), 
with greater affinity than BPA; therefore we suggest them as priority compounds to be tested 
against this disease. The two best affinity scores in this group were obtained for bisphenol M in 
complex with SRC, a protein that may promote the growth of tumor cells and is overexpressed in 
breast cancer35; and for BPAF with ESRRG, an orphan nuclear receptor widely implicated in the 
transcriptional regulation of energy homeostasis36 that acts as tumor suppressor in several types 
of cancers37. Interestingly BPAF, has been found to promote breast cancer cell proliferation in 
vitro38, and bisphenol M exhibited high predicted affinity (<-10.0 kcal/mol) for several proteins 
related to breast cancer. 
 
A small number of compounds released from household products, cosmetics, drugs and 
personal care products were found to bind strongly breast cancer proteins in silico (<-10.0 
kcal/mol, Table 3). Among these, perfluorooctane sulfonic acid, used in the manufacture of 
plastics, textiles, electronics, and many other industrial products39; AHTN found in cosmetics40; 
emodin a medicine that has been found to suppress tumor growth41; 3-(4-
methylbenzylidene)camphor employed as UV filter in cosmetics42; and triclocarban, frequently 
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utilized in detergents and soaps as antimicrobial agent43. Nevertheless, there were many 
molecules in this group that presented moderate and weak binding that eventually could have a 
role in the homeostasis disruption in relation to the development or progression of this disease. 
On the other hand, several of the targeted proteins for these compounds are shared with the top 
list for plastics and related molecules, as well as with the proteins most frequently found in 
theoretical EDCs-breast cancer protein complexes, some of them are SHBG, RARB, CAT and 
vitamin D3 receptor (VDR).  
 
In contrast, a large number of PAHs, derived from combustion, occupied the top ranking of 
complexes formed for miscellaneous EDCs. Some of these are the well-known carcinogen 
benzo(a)pyrene, benzanthrone, 6-hydroxychrysene and 1-hydroxypyrene. This type of molecules 
has been classically associated to breast cancer through genetic damage by DNA adduct 
formation44, however they could also be acting throw protein-ligand interactions. In addition, 
other molecules from diverse sources also exhibited high affinity for breast cancer proteins such 
as: HHCB, used in fragrances40; the chemical indicator aurin45; and the flame retardant 3-
monobromobisphenol A46; among others (Table 4). 
  
The computer simulations of the docking poses and protein-ligand interaction analysis in the 
top complexes of each category showed that the most frequent binding forces were due to 
hydrophobic, hydrogen bond donor, hydrogen bond acceptor and aromatic ring features of the 
ligands and contact residues in the binding site. The conformational study of the protein-ligand 
pair selected for in vitro assays, SHBG/BPA, showed that the predicted interacting residues 
(Met139A, Thr60A, Phe67A, Leu80A and Val112A), are the same found experimentally on the 
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binding site of endogenous hormones and xenoestrogens, that binds this protein with high 
affinity47. Therefore, BPA may occupy the pocket for natural estrogens in the body, reducing the 
fraction of bound estrogen and increasing its bioavailability48, which is considered a risk factor 
to develop this disease18.  
 
The recombinant human SHBG used in our spectroscopic analysis was obtained without any 
mutation, and according to the MST analysis it was functional, and their folding was the 
expected, as assessed by the circular dichroism spectra of the native protein without the ligand. 
The differences in the circular dichroism spectra of SHBG and SHBG with BPA may be the 
result of both BPA binding and the dimerization of the protein, as has been reported with steroid 
ligands that bind this protein with high affinity49. The main conformational change occurred after 
BPA binding was an increment of the alpha helix content after overnight incubation, this result 
has also been observed for the binding of this molecule to other proteins, such as human serum 
albumin50. The Dunn’s test showed statistical differences in the spectra for overnight incubation 
with BPA, but not for the immediate CD recorded after BPA addition (time zero), suggesting 
that the reaction between BPA and SHBG, may be time-dependent. This is not surprising, as 
related studies regarding binding assays, used the same physiologic conditions of pH and 
temperature as in our protocol, as well as an incubation time of at least one hour48a.  
 
The results discussed in this section showed the plausibility of some EDCs to interact with 
proteins involved in signaling pathways regarding breast cancer. Therefore further analysis in 
this field is needed to support regulatory actions, being of special concern the case of the new 
BPA analogs. 
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4. CONCLUSIONS 
 
This study presents a virtual screening that helps to understand how endocrine disruptors could be 
plausible ligands for the breast cancer proteome. This approach provided, important candidates to be 
evaluated in vitro against models of this disease, predicting protein patterns of proteins that are more 
commonly affected by EDCs. Many of the predicted hits have no scientific reports regarding its 
experimental evaluation; therefore further studies are required in this field. Computational studies are an 
important tool that can improve the velocity and efficiency of the evaluations of EDCs overcoming the 
known limitations regarding the high number of this compounds and diseases associated to them. Several 
endocrine disruptors have the theoretical capability to bind proteins related to breast cancer, some of them 
are more promiscuous being able to bind different targets, therefore this are proposed as priority for 
experimental test. BPA binds SHBG, showing a conformational change of the protein. 
 
5. EXPERIMENTAL SECTION 
A four-step approach has been used to identify EDCs with potential to target breast cancer 
proteins. This includes the selection of the proteins by data mining tools, vHTS, evaluation of in 
silico interactions and experimental validation by spectroscopic methods. 
 
5.1.Text mining 
Proteomics studies of breast cancer have provided relevant information regarding the 
identification of proteins of interest in the diagnosis and treatment of this disease51, even though 
there is not a consensus list or repository with this information. Therefore, a meta-analysis was 
performed to identify proteins and genes associated with breast cancer in PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed/), using the text mining tool FABLE (Fast Automated 
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Biomedical Literature Extraction; http://fable.chop.edu/), employing the key words “breast 
cancer”. The results were ranked according to their number of hits, and a cutoff of ≥100 
references related to breast cancer in PubMed was used. This methodology was carried out in 
order to include the proteins more frequently cited with a role in breast cancer. Some important 
nuclear receptors and cell cycle targets were also included, as they have been reported to be 
deregulated in human breast cancer1a, 52. 
   
5.2.High-throughput virtual screening 
Molecular docking simulations were carried out to find EDCs with the potential to target breast 
cancer proteins in silico. Calculations were run on Linux RHEL6 for IBM Power, utilizing a 
System X rack with Power 730 processors. AutoDock Vina13, an open-source program for 
molecular docking and virtual screening, was used to assess the binding affinity of each 
EDC/protein complex, as this software has been largely employed and formally validated for 
target identification of this kind of molecules, having a high prediction performance when 
compared to experimental data53, not only regarding the binding affinity but also the 
crystallographic binding modes54. A total of 305 EDCs from urban sources were downloaded 
from EDCs DataBank55 and docked with the selected breast cancer proteins, using the same 
protocol reported in our previous work for inverse virtual screening1a. The crystallographic 
coordinates of the proteins, with resolution suitable for docking studies (in average, 2.0 Å), were 
downloaded from Protein Data Bank (PDB)23 in pdb text format file which were then employed 
for preprocessing in SYBYL-X 2.0 program package (Tripos, St. Louis, MO). All ions, water 
molecules and other substructures were removed from the coordinated files and the biopolymer 
structure preparation tool was used for analyzing and fixing the 3D-structures with default 
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settings. Optimization of the proteins was also carried out by the same software package 
employing the Powell method, Kollman united and Kollman all atoms force fields, AMBER 
charges, dielectric constant 1.0, NB cutoff 8.0, maximum interactions 100 and termination 
gradient 0.001 kcal/mol. The resultant pdb file was then submitted to AutoDock Tools56 for 
preparing the grid parameters and the required pdbqt files for the docking studies. Kollman 
charges and polar hydrogen atoms were added to the three-dimensional structures of the proteins, 
the grid was centered in the macromolecule and the size adjusted to include the whole protein 
surface with a spacing of 0.357 Å. The structures of the EDCs were directly downloaded from 
EDCs DataBank55, and used for virtual screening in Autodock Vina13. Each ligand/protein pair 
was docked by triplicate and the best Affinity scores of the single runs were then used to 
calculate the averages and the results ranked according to these values. 
 
The EDCs were separated according to their source of exposure in four groups: dioxins and 
related molecules, plastics and other types of polymers, everyday products and miscellaneous. 
The results ranked and the best protein/ligand complexes of each category were then selected to 
determine their non-covalent interactions by computer aided simulations. In addition, a 
hierarchical clustering, which is a powerful tool to blindly explore proteomic data57, was 
performed in R (http://www.r-project.org/) for each group, using the “heatmap.2” function of the 
gplot library58. The color key of the heat map, was selected using the RColorBrewer package of 
R, to present in red the protein-ligand pairs with strong and moderate docking affinity (-15.0 to -
8.0 kcal/mol), in white those with weak affinity (-8.0 to -7.0 kcal/mol) and in blue the proteins-
ligand pairs that are not likely to interact according to the simulation (-7.0 to 5.0 kcal/mol). As a 
result, patterns in the behavior of EDCs against breast cancer proteins and vice versa were 
Page 35 of 50
ACS Paragon Plus Environment
Chemical Research in Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 36 
identified. The employed affinity cutoff (< -8.0 kcal/mol) was the same used in the protocol of 
our previous studies with AutoDock Vina13, which allowed a good correlation between in silico 
binding affinity and experimental data54, 59.  
 
5.3.Evaluation of protein-ligand interactions 
An in silico approach was employed to evaluate the contact residues participating in the 
protein-ligand interaction in selected complexes formed between breast cancer related proteins 
and EDCs. This was achieved using LigandScout 3.122. The best docking pose of the EDC 
resulting from the docking with the target protein by AutoDock Vina13 was isolated in AutoDock 
Tools56 and merged with the optimized file of the protein structure in pdb format by SYBYL X-
2.0 (Tripos, St. Louis, MO). This file was then used as input in LigandScout, the parameters 
utilized for the pharmacophore features and interacting residues were those established by 
default in the program.  
 
In order to validate our protocol, a protein-ligand pair, was selected for studying its 
interactions in silico and in vitro. The criteria used to pick the complex that exhibited an Affinity 
score near the cutoff (around -8.0 kcal/mol), a common EDC with generalized exposure in the 
population and a protein with certain impact in breast cancer.  
 
5.4.Experimental validation of the existence of protein-ligand interactions for a predicted 
EDC/protein complex 
The protein ligand interaction between bisphenol A (BPA), one of the most common EDCs 
used in plastics60, and the steroid transporter protein sex hormone-binding globulin (SHBG) was 
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analyzed by LigandScout software22, using the same protocol described above; and the validation 
of the binding and conformational changes of this complex was achieved by spectroscopic 
methods61, employing microscale thermophoresis (MST) and circular dichroism (CD). The 
protein was obtained by recombinant DNA technology and BPA (≥99%; 239658-50G) was 
purchased from Sigma Aldrich. 
 
5.5.Protein expression and purification 
The blank plasmid pET15-MHL was transfected into the gene for human SHBG (PDB: 1F5F) 
(obtained from Eurofins, Ebersberg), and then harbored in Escherichia coli DH5α cells. The 
plasmid was purified and transformed into chemically competent E. coli C41(DE3). Transformed 
cells were plated onto LB agar containing 100 μg/mL of ampicillin, and incubated overnight at 
37 °C. A single colony was used to inoculate 100 mL of LB/ampicillin for overnight growth. 20 
mL of the starting solution was used to inoculate 400 mL of LB/ampicillin medium. The culture 
was incubated at 37 °C (180 rpm) until the A600 was 0.6–0.8 at which point protein expression 
was induced by the addition of isopropyl 1-thio-β-d-galactopyranoside (IPTG) to a final 
concentration of 0.5 mM. After overnight incubation at 20 °C62, the induced cells were harvested 
by centrifugation, the pellet was resuspended in cold PBS buffer and washed twice, resuspended 
again in 15 mL of cold lysis buffer (150 mM sodium chloride, 1.0% Triton X-100, 50 mM Tris, 
pH 8.0), maintained in agitation 30 min (4°C), and centrifuged (20 min, 12,000 rpm). This pellet 
was discarded and the supernatant was placed on ice, and stored at −20 °C until protein 
purification (http://www.abcam.com/index.html?pageconfig=resource&rid=11379). Magnetic 
beads (Dynabeads His-Tag Isolation and Pulldown (Life technologies) were used for protein 
purification according to the protocol provides by the supplier 
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(http://tools.lifetechnologies.com/content/sfs/manuals/DynabeadsHisTagIsolationPulldown_man.
pdf). A dialysis procedure was also employed to remove small molecules using a slide-A-Lyzer 
Dialysis Cassette, 20K MWCO (Thermo scientific) according to the protocol provided by the 
supplier, and a SDS electrophoresis gel was run to check the presence and quality of the protein. 
 
5.6.Protein storage  
In order to avoid frequent freezing and thawing, the protein sample was divided into aliquots, 
stored frozen at -20°C, and kept at physiological pH (PBS buffer pH 7.4). 
 
5.7.Microscale Thermophoresis (MST) 
In order to evaluate the likelihood of a possible functionality of BPA binding on SHBG, a 
qualitative MST analysis was carried out. This method reflects the directed movement of 
particles in a microscopic temperature gradient, and enables the analysis of molecular 
interactions in solution at microliter scale63, with low sample consumption64. 
 
The SHBG protein was labeled using the blue fluorescent dye NT-495-NHS (NanoTemper 
Technologies) and incubated for 1 hour at room temperature. In order to separate the free dye 
from the protein, a superdex 200 10/300GL column and an AKTA PURE FPLC system (GE 
Healthcare) were utilized with PBS buffer pH 7.4 at 0.5 mL/s flow rate. Fractions of 0.25 mL 
were collected with a fraction collector F9-R (GE Healthcare). The labeled SHBG was incubated 
for 5 min at room temperature with different concentrations of BPA in PBS containing 5% 
ethanol as vehicle, testing 1:2 concentrations from 0.03 to 1000 nM (1 µM). The samples (3–5 
µL) were loaded into hydrophilic glass capillaries (Monolith NT Capillaries) and the 
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thermophoresis analysis was performed (LED 40%, IR laser 20%) using a NanoTemper 
Monolith NT.115 (NanoTemper Technologies) instrument. The capillary used for the MST 
analysis with BPA and SHBG was the hydrophilic one, as this generated the expected Gaussian 
curve. 
 
5.8.Circular Dichroism 
A stock solution consisted of a 30 mM BPA solution in absolute ethanol. The spectra of SHBG 
(1 μM in Tris pH 7.4) was analyzed to characterize the non-bonded folding state of the 
recombinant protein, by comparison with the information provided in PDB23. The changes in the 
secondary structure of the protein after BPA binding were accessed by recording the circular 
dichroism (CD) spectra of SHBG with two concentrations of BPA (1.5 x 10-5 and 4.5 x 10-5 M) 
at time zero and after overnight incubation. The solutions were prepared adding 0.2 and 0.6 μL 
of the BPA stock solution (30 mM) to 400 μL of SHBG (1 μM in Tris pH 7.4), respectively. The 
TRIS buffer was used as background and subtracted from all runs. The CD spectra were recorded 
using the applied photophysics Chriscan, wavelength (nm): 190-350; step: 0.5; time per point (s): 
0.5 repeats: 5, temperature: 25°C and auto-subtraction of the background. All the spectra were 
recorded in both delta A and mdeg units, with 5 repetitions, using a quartz cuvette of 10 mm path 
length, volume: 0.7 mL, inside: 2 mm; spectral range 190-2500 nm; 4 transparent windows and 
dimensions 45 mm x 12.5 mm x 12.5 mm, in a nitrogen atmosphere50. The data was recorded 
using the programs Prodata viewer, Chirascan and APLData Converter. The circular dichroism 
spectra were saved as ASCII files (.kin file format), employing the Pro-data Chriscan software, 
and utilized as input files in DichroWeb24 for the secondary structure determination. The 
parameters used were: file format=free, input units=milidegrees, initial wavelength=190, final 
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wavelength=350, wavelength step=0.5, lowest datapoint to use in the analysis=190, analysis 
program=CONTIN, reference set=SMP 180 (Optimized for 190-240 nm), Optional scaling 
factor=1, Output units=delta epsilon. A statistical analysis of the results of the CD was 
performed by GraphPad Prism 6.01 (GraphPad Software Inc., San Diego, CA, USA). A non-
parametric multiple comparison test Kruskal-Wallis was performed using the raw data of the 
spectra recorded for SHBG and SHBG/BPA, besides a post-hoc Dunn’s multiple comparison test 
of the row data based on Kruskal-Wallis analysis was also applied to compare the medians of the 
individual groups. Statistical significance was accepted at p ≤ 0.05.  
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ABBREVIATIONS 
ADIPOQ, adiponectin; APOD, apolipoprotein D; BPA, bisphenol A; BPAF, bisphenol AF; 
BRCA1, breast cancer type 1 susceptibility protein; BRCA2, breast cancer type 2 susceptibility 
protein; CAT, catalase; CD, circular dichroism; CDK2, cyclin-dependent kinase 2; CHEK2, 
serine/threonine-protein kinase Chk2; CYP1A2, cytochrome P450 1A2; CYP2B6, cytochrome 
P450 2B6; CYP3A4, cytochrome P450 3A4; EDCs, endocrine disrupting chemicals; EPA, 
Environmental Protection Agency; ESR1, estrogen receptor; ESRRG, estrogen-related receptor 
gamma; FABLE, fast automated biomedical literature extraction; GSTP1, glutathione S-
transferase P; HBA1, hemoglobin subunit alpha; HER-2, human epidermal growth factor 
receptor 2; HPGDS , hematopoietic prostaglandin D synthase; HTS, high-throughput screening; 
IPTG, isopropyl 1-thio-β-d-galactopyranoside MET , hepatocyte growth factor receptor; MMP9, 
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matrix metalloproteinase-9; MST, microscale thermophoresis; MYLK4, myosin light chain 
kinase family member 4; NME1, nucleoside diphosphate kinase A; NP2, nitrophorin-2; NQO1, 
NAD(P)H dehydrogenase [quinone] 1; NR3C1, glucocorticoid receptor; OH-PCBs Hydroxylated 
polychlorinated biphenyls; O/N, overnight; PAHs, polycyclic aromatic hydrocarbons; PCBs, 
polychlorinated biphenyls; PDB, Protein Data Bank; PGR, progesterone receptor; PIK3CA, 
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; RARB, retinoic 
acid receptor beta; RXRG , retinoic acid receptor RXR-gamma; RORA, nuclear receptor ROR-
alpha; RORC, nuclear receptor ROR-gamma; RPS6KB1, ribosomal protein S6 kinase beta-1; 
SHBG, sex hormone-binding globulin; SRC , proto-oncogene tyrosine-protein kinase Src; VDR, 
vitamin D3 receptor; vHTS, virtual high-throughput screening; WHO, World Health 
Organization. 
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